- Home
- TLSI vs EVGO Comparison
TLSI vs EVGO Comparison
Compare TLSI & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | EVGO |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | 110 | 331 |
| Industry | Medical Specialities | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 308.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | EVGO |
|---|---|---|
| Price | $4.25 | $1.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $7.00 | $5.23 |
| AVG Volume (30 Days) | 190.8K | ★ 4.9M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.47 | $16.45 |
| Revenue Next Year | $39.31 | $29.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.42 | $1.64 |
| 52 Week High | $7.95 | $5.18 |
Technical Indicators
Market Signals| Indicator | TLSI | EVGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 29.12 |
| Support Level | $3.79 | N/A |
| Resistance Level | $5.33 | $3.27 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 81.82 | 13.21 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.